The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Occupancy of Serotonin Transporters by Paroxetine and Citalopram During Treatment of Depression: A [11C]DASB PET Imaging Study
Abstract
OBJECTIVE: Selective serotonin reuptake inhibitors are commonly used to treat major depression; however, the percentage of serotonin (5-HT) transporter (5-HTT) sites occupied during clinical dosing is unknown. This study measured the proportion of 5-HTT sites blocked during paroxetine and citalopram treatment of depression and assessed the relationship between serum paroxetine levels and the proportion of 5-HTT sites blocked. METHOD: Twelve medication-free depressed patients completed a 6-week trial of either paroxetine (N=8) or citalopram (N=4). Striatal 5-HTT binding potential was measured with [(11)C]DASB and positron emission tomography, before and after 4 weeks of treatment. The binding potential is proportional to receptor density. Striatal 5-HTT binding potential was measured twice in six healthy subjects and once in 11 healthy subjects. RESULTS: A significant decrease in striatal 5-HTT binding potential was found after either treatment, compared to changes found over a 4-week period in healthy subjects. For patients treated with 20 mg/day of paroxetine (N=7), the mean proportion of 5-HTT sites occupied was 83%. For patients treated with 20 mg/day of citalopram (N=4), the mean 5-HTT occupancy was 77%. 5-HTT occupancy increased in a nonlinear relationship with serum levels of paroxetine such that a plateau of occupancy around 85% occurred for serum paroxetine levels greater than 28 microg/liter. CONCLUSIONS: During treatment with clinical doses of paroxetine or citalopram, approximately 80% of 5-HTT receptors are occupied. This change in 5-HTT binding potential is greater than the known physiological range of changes in 5-HTT binding potential but may be necessary for some therapeutic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
An overlap invariant entropy measure of 3D medical image alignment
Studholme, C., Hill, D. L. G., & Hawkes, D. J. (1999) · Pattern Recognition · doi:10.1016/s0031-3203(98)00091-0 · Cited by 2,180
Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F., & Welch, M. J. (1984) · Annals of Neurology · doi:10.1002/ana.410150302 · Cited by 955
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Malison, R. T., Price, L. H., Berman, R., van Dyck, C. H., Pelton, G. H., Carpenter, L., Sanacora, G., Owens, M. J., Nemeroff, C. B., Rajeevan, N., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00272-8 · Cited by 496
5-HT2and D2Receptor Occupancy of Olanzapine in Schizophrenia: A PET Investigation
Kapur, S., Zipursky, R. B., Remington, G., Jones, C., DaSilva, J., Wilson, A. A., & Houle, S. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.921 · Cited by 370
Self-citationBenmansour, S., Cecchi, M., Morilak, D. A., Gerhardt, G. A., Javors, M. A., Gould, G. G., & Frazer, A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10494.1999 · Cited by 337
Houle, S., Ginovart, N., Hussey, D., Meyer, J. H., & Wilson, A. A. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000365 · Cited by 276
Self-citationBel, N., & Artigas, F. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90292-c · Cited by 269
Nyberg, S., Eriksson, B., Oxenstierna, G., Halldin, C., & Farde, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.869 · Cited by 251
Wilson, A. A., Ginovart, N., Schmidt, M., Meyer, J. H., Threlkeld, P. G., & Houle, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000079i · Cited by 249
Self-citationThe Effect of Paroxetine on 5-HT2A Receptors in Depression: An [18F]Setoperone PET Imaging Study
Meyer, J. H., Kapur, S., Eisfeld, B., Brown, G. M., Houle, S., DaSilva, J., Wilson, A. A., Rafi-Tari, S., Mayberg, H. S., & Kennedy, S. H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.78 · Cited by 231
Self-citationCortés, R., Soriano, E., Pazos, A., Probst, A., & Palacios, J. M. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90282-5 · Cited by 217
Lesch, K. P., Aulakh, C. S., Wolozin, B. L., Tolliver, T. J., Hill, J. L., & Murphy, D. L. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90069-2 · Cited by 208
Radiotracer synthesis from [11C]-iodomethane: a remarkably simple captive solvent method
Wilson, A. A., Garcia, A., Jin, L., & Houle, S. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00132-3 · Cited by 201
Self-citationDesensitization of the neuronal 5-HT carrier following its long-term blockade
Pineyro, G., Blier, P., Dennis, T., & de Montigny, C. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03036.1994 · Cited by 179
Willeit, M., Praschak-Rieder, N., Neumeister, A., Pirker, W., Asenbaum, S., Vitouch, O., Tauscher, J., Hilger, E., Stastny, J., Brücke, T., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00293-0 · Cited by 179
Szabo, Z., Kao, P. F., Scheffel, U., Suehiro, M., Mathews, W. B., Ravert, H. T., Musachio, J. L., Marenco, S., Kim, S. E., Ricaurte, G. A., et al. (1995) · Synapse · doi:10.1002/syn.890200107 · Cited by 170
Multicenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression
Feighner, J. P., & Overø, K. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1204 · Cited by 168
Laruelle, M., Vanisberg, M.-A., & Maloteaux, J.-M. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90198-9 · Cited by 166
High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue
Ba¨ckstro¨m, I., Bergstro¨m, M., & Marcusson, J. (1989) · Brain Research · doi:10.1016/0006-8993(89)90511-8 · Cited by 162
In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.
Parsey, R. V., Kegeles, L. S., Hwang, D., Simpson, N. R., Abi‐Dargham, A., Mawlawi, O. R., Slifstein, M., Heertum, R. L. V., Mann, J. J., & Laruelle, M. A. (2000) · PubMed · Cited by 136
Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.
Ichise, M., Ballinger, J. R., Golan, H., Vines, D. C., Luong, A., Tsai, S., & Kung, H. F. (1996) · PubMed · Cited by 133
?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo
Pirker, W., Asenbaum, S., Kasper, S. F., Walter, H., Angelberger, P., Koch, G., Pozzera, A., Deecke, L., Podreka, I., & Br�cke, T. (1995) · Journal of Neural Transmission · doi:10.1007/bf01276462 · Cited by 127
Age-related decline in central serotonin transporter availability with [123I]β-CIT SPECT
van Dyck, C. H., Malison, R. T., Seibyl, J. P., Laruelle, M. A., Klumpp, H., Zoghbi, S. S., Baldwin, R. M., & Innis, R. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00152-4 · Cited by 119
Low-dose fluoxetine therapy for depression.
Wernicke, J. F., Dunlop, S. R., Dornseif, B. E., Bosomworth, J. C., & Humbert, M. (1988) · PubMed · Cited by 101
Moret, C., & Briley, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00646-x · Cited by 83
Dewar, K. M., Grondin, L., Carli, M., Lima, L., & Reader, T. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09303.x · Cited by 79
The Hamilton Rating Scale for depression: a factor analysis
Mowbray, R. M. (1972) · Psychological Medicine · doi:10.1017/s0033291700042574 · Cited by 71
Schmidt, M. E., D, M. F. M., Robinson, J. M., & Judge, R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1107 · Cited by 68
Kapur, S., Cho, R., Jones, C., McKay, G., & Zipursky, R. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00204-2 · Cited by 65
Laruelle, M. A., Giddings, S. S., Zea‐Ponce, Y., Charney, D. S., Neumeyer, J. L., Baldwin, R. M., & Innis, R. B. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62030978.x · Cited by 62
p‐Chlorophenylalanine Changes Serotonin Transporter mRNA Levels and Expression of the Gene Product
Rattray, M., Baldessari, S., Gobbi, M., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020463.x · Cited by 57
Lesch, K., Heils, A., & Riederer, P. F. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00210631 · Cited by 42
Modeling of Receptor Ligand Data in PET and SPECT Imaging: A Review of Major Approaches
Meyer, J. H., & Ichise, M. (2001) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2001.tb00006.x · Cited by 33
Self-citationSpencer, E. P. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199908000-00227 · Cited by 4
Ciliax (1999) · doi:10.1002/(sici)1096-9861(19990621)409:1<38::aid-cne4>3.0.co;2-1
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,313
Fu, C. H. Y., Williams, S. C. R., Cleare, A. J., Brammer, M. J., Walsh, N. D., Kim, J., Andrew, C. M., Pich, E. M., Williams, P. M., Reed, L. J., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.9.877 · Cited by 775
Meyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517
Self-citationHow psychotherapy changes the brain – the contribution of functional neuroimaging
Linden, D. E. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001816 · Cited by 491
Metadata
- Authors
- Meyer, J. H., Wilson, A. A., Ginovart, N., Goulding, V., Hussey, D., Hood, K., & Houle, S.
- Venue
- American Journal of Psychiatry
- Published
- 2001-11-01
- Volume
- 158
- Issue
- 11
- Pages
- 1843-1849
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2125228745
- Cited by
- 340
- References
- 37
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.